FDA’s Approach to Evaluating Nicotine Replacement Therapies; Public Hearing; Request for Comments

RIN

—

Last modified

Mar 5, 2018

Comment window

closed 3085d ago

Consumer Healthcare Products Association filings

Activity

Consumer Healthcare Products Association filed 1 comment on this docket between Mar 5, 2018 and Mar 5, 2018. 9 other organizations filed here. The comment window closed 3085d ago.

What Consumer Healthcare Products Association filed (1)

Mar 5, 2018· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2017-N-6529-0061

Comments from the Consumer Healthcare Products Association concerning FDA's public hearing and request for comments on the agency's approach to evaluating nicotine replacement therapies are attached.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (9)

See everyone who commented →

Consumer Healthcare Products AssociationTHIS ORG
1 filing · confidence 97%
American Academy of Pediatrics (AAP)
2 filings · confidence 97%
Foundation for a Smoke-Free Worldtrade assoc.
2 filings · confidence 85%
American Association for Cancer Researchtrade assoc.
1 filing · confidence 85%
American Cancer Society Cancer Action Networktrade assoc.
1 filing · confidence 85%
American Lung Associationtrade assoc.
1 filing · confidence 85%
American Thoracic Societytrade assoc.
1 filing · confidence 85%
Association for the Treatment of Tobacco Use and Dependencetrade assoc.
1 filing · confidence 85%
Harmless Product Companyunverified attribution
1 filing · confidence 70%
Johnson & Johnson Consumer Services EAME Ltdunverified attribution
1 filing · confidence 70%